We are live on ! Find out more
CNCE

Concert Pharmaceuticals, Inc.
CNCE

Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

52 hedge funds and large institutions have $57.1M invested in Concert Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 21 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more call options, than puts

Call options by funds: $164K | Put options by funds: $81K

0% more capital invested

Capital invested by funds: $57.1M → $57.1M (+$2.93K)

15% less funds holding

Funds holding: 61 → 52 (-9)

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

48% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 21

Holders
52
Holders Change
-9
Holders Change %
-14.75%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
21
Closed
19
Calls
$164K
Puts
$81K
Net Calls
+$83K
Net Calls Change
+$54K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$7.5M
2
NW
NewEdge Wealth
Pennsylvania
+$1.27M
3
Millennium Management
Millennium Management
New York
+$737K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$274K
5
Morgan Stanley
Morgan Stanley
New York
+$266K

Top Sellers

Rank Fund Capital Flow
1
ISL
Ingalls & Snyder LLC
New York
-$1.31M
2
SW
SVB Wealth
Massachusetts
-$1.25M
3
GCP
GSA Capital Partners
United Kingdom
-$1.24M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.2M
5
BlackRock
BlackRock
New York
-$894K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
51
Jacobs Levy Equity Management
New Jersey
– -$1.2M -366,448 Closed
E
52
Ergoteles
New York
– -$415K -126,838 Closed
HF
53
HRT Financial
New York
– -$223K -68,379 Closed
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
– -$171K -51,294 Closed
Russell Investments Group
55
Russell Investments Group
United Kingdom
– -$139K -42,976 Closed
Wells Fargo
56
Wells Fargo
California
– -$100K -30,150 -99%
Squarepoint
57
Squarepoint
New York
– -$89K -27,233 Closed
Simplex Trading
58
Simplex Trading
Illinois
– -$57.5K -17,288 Closed
Ohio Public Employees Retirement System (OPERS)
59
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$56K -17,125 Closed
Goldman Sachs
60
Goldman Sachs
New York
– -$52K -15,773 Closed
ASN
61
Advisory Services Network
Georgia
– -$43K -13,300 Closed
Zurich Cantonal Bank
62
Zurich Cantonal Bank
Switzerland
– -$15K -4,501 Closed
JP Morgan Chase
63
JP Morgan Chase
New York
– -$7.53K -2,262 -98%
TFO
64
Tarbox Family Office
California
– -$7K -2,000 Closed
Citigroup
65
Citigroup
New York
– -$5K -1,669 Closed
QT
66
Quantbot Technologies
New York
– -$3K -1,034 Closed
Fidelity Investments
67
Fidelity Investments
Massachusetts
– -$3K -775 Closed
PCM
68
Penserra Capital Management
California
– -$2K -740 Closed
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
– +$133 +40 New
1 2
3

CNCE Hedge Fund Activity: Q4 2021 in Review

52 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Concert Pharmaceuticals, Inc. (CNCE) for Q4 2021, worth a combined $57.1M — up 0.01% from $57.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CNCE and 10 opened new positions — a net loss of 9 holders — while 21 trimmed existing stakes and 11 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $7.5M. The largest seller was Ingalls & Snyder LLC, cutting an estimated $1.31M.

  • 52 institutional investors held Concert Pharmaceuticals, Inc. (CNCE) as of Q4 2021, down from 61 in Q3 2021.
  • Funds reported $57.1M of Concert Pharmaceuticals, Inc. stock for Q4 2021, up 0.01% quarter-over-quarter.
  • 10 funds opened new Concert Pharmaceuticals, Inc. positions in Q4 2021 and 19 closed out, a net change of -9 holders.
  • The largest Concert Pharmaceuticals, Inc. buyer in Q4 2021 was BVF Inc, an estimated $7.5M added.
  • The largest Concert Pharmaceuticals, Inc. seller in Q4 2021 was Ingalls & Snyder LLC, an estimated $1.31M sold.

Based on aggregated 13F filings for Q4 2021.